Bonus Issue of Options and Other Corporate Updates

Melodiol Global Health Limited (ASX:ME1, FRA:1X8) (‘Melodiol’ or ‘the Company’) is pleased to announce a pro- rata non-renounceable bonus issue of options to eligible shareholders on the basis of one (1) option (“Bonus Option”) for every twenty (20) fully paid ordinary shares (“Shares”) held on the Record Date, with the Bonus Option to be issued for nil consideration (“Bonus Offer”). The record date for the Bonus Offer is anticipated to be in early November 2023 (“Record Date”).

The purpose of the Bonus Offer is to recognise the support and loyalty the Company has received from its shareholders to date, especially in the backdrop of challenging macro market conditions.

The Bonus Offer is being made to all shareholders of the Company named on its register of members at the Record Date, whose registered address is in Australia, New Zealand, or any other jurisdictions to whom the Company decides to make the Bonus Offer (“Eligible Shareholders”).

The Bonus Options will be exercisable at $0.01 on or before 5:00pm (WST) on the date that is five years from the date of issue. The Company will seek official quotation of the Bonus Options on the ASX.

Based on the number of Shares on issue at the date of this announcement, a total of 160,564,889 Bonus Options will be issued pursuant to the Bonus Offer. For the purpose of calculating each Eligible Shareholder’s entitlement, fractional entitlements will be rounded down to the nearest whole number.

Full details of the Bonus Offer will be set out in a prospectus to be lodged by the Company on the ASX in early November 2023.

Other Corporate Updates

May Placement Update

Additionally, the Company provides the following update in respect of the placement undertaken in May 2023 (refer to ASX announcement dated 19 May 2023). The Company advises that one participant, who committed to providing $350,900 has yet to provide funds to the Company. The Company has persistently attempted to enforce that the investor comply with their obligations, however given the length of time that has passed, the Company now considers that it is unlikely to receive this commitment and therefore updates the market as such.

Click here for the full ASX Release

This article includes content from Melodiol Global Health, licensed for the purpose of publishing on Investing News Australia. This article does not constitute financial product advice. It is your responsibility to perform proper due diligence before acting upon any information provided here. Please refer to our full disclaimer here.

asx:me1 melodiol global health limited psychedelics investing cannabis investing

ME1:AU

Trulieve Announces January 2025 Event Participation

Trulieve Cannabis Corp. (CSE: TRUL ) (OTCQX: TCNNF ) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S., today announced planned event participation in January.

27 ^th Annual Needham Growth Conference, January 17, 2025 : Vice President of Investor Relations Christine Hersey will participate in a presentation and investor meetings.

Information about our events, links to events where available, and slide presentations can be found at: https://investors.trulieve.com/events

About Trulieve
Trulieve is an industry leading, vertically integrated cannabis company and multi-state operator in the U.S., with leading market positions in Arizona , Florida , and Pennsylvania . Trulieve is poised for accelerated growth and expansion, building scale in retail and distribution in new and existing markets through its hub strategy. By providing innovative, high-quality products across its brand portfolio, Trulieve delivers optimal customer experiences and increases access to cannabis, helping patients and customers to live without limits. Trulieve is listed on the CSE under the symbol TRUL and trades on the OTCQX market under the symbol TCNNF. For more information, please visit Trulieve.com.

Facebook: @Trulieve
Instagram: @Trulieve _
X: @Trulieve

Investor Contact
Christine Hersey , Vice President of Investor Relations
+1 (424) 202-0210
Christine.Hersey@Trulieve.com

Media Contact
Phil Buck , APR, Corporate Communications Manager
+1 (406) 370-6226
Philip.Buck@Trulieve.com

View original content to download multimedia: https://www.prnewswire.com/news-releases/trulieve-announces-january-2025-event-participation-302346620.html

SOURCE Trulieve Cannabis Corp.

View original content to download multimedia: http://www.newswire.ca/en/releases/archive/January2025/09/c9006.html

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less

Trulieve Announces January 2025 Event Participation

Trulieve Cannabis Corp. (CSE: TRUL ) (OTCQX: TCNNF ) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S., today announced planned event participation in January.

27 ^th Annual Needham Growth Conference, January 17, 2025 : Vice President of Investor Relations Christine Hersey will participate in a presentation and investor meetings.

Information about our events, links to events where available, and slide presentations can be found at: https://investors.trulieve.com/events

About Trulieve
Trulieve is an industry leading, vertically integrated cannabis company and multi-state operator in the U.S., with leading market positions in Arizona , Florida , and Pennsylvania . Trulieve is poised for accelerated growth and expansion, building scale in retail and distribution in new and existing markets through its hub strategy. By providing innovative, high-quality products across its brand portfolio, Trulieve delivers optimal customer experiences and increases access to cannabis, helping patients and customers to live without limits. Trulieve is listed on the CSE under the symbol TRUL and trades on the OTCQX market under the symbol TCNNF. For more information, please visit Trulieve.com.

Facebook: @Trulieve
Instagram: @Trulieve _
X: @Trulieve

Investor Contact
Christine Hersey , Vice President of Investor Relations
+1 (424) 202-0210
Christine.Hersey@Trulieve.com

Media Contact
Phil Buck , APR, Corporate Communications Manager
+1 (406) 370-6226
Philip.Buck@Trulieve.com

View original content to download multimedia: https://www.prnewswire.com/news-releases/trulieve-announces-january-2025-event-participation-302346620.html

SOURCE Trulieve Cannabis Corp.

View original content to download multimedia: http://www.newswire.ca/en/releases/archive/January2025/09/c9006.html

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less

10 Biggest Cannabis Stocks in the US and Canada

2024 saw the cannabis industry grappling with persistent challenges, mirroring those of the preceding two years. The absence of meaningful regulatory reform in both the US and Canada continues to stifle market growth

There was some positive momentum in the US as new markets entered the industry and the US Drug Enforcement Administration moved to reschedule cannabis from Schedule I to Schedule III; however, subsequent roadblocks suggest the process could take longer than industry hopefuls originally anticipated.

Cannabis companies in the sector continue to move forward and develop their offerings, and with potential catalysts ahead some investors are interested in getting involved. Looking at the key players is often a good place to get started, so this list of US and Canadian cannabis stocks covers the companies with the largest presence in two major cannabis ETFs.

This list of the biggest publicly traded cannabis companies was put together based on the top-weighted cannabis stocks included in the AdvisorShares Pure US Cannabis ETF (ARCA:MSOS) and the Horizons Marijuana Life Sciences Index ETF (TSX:HMMJ) as of December 23, 2024. Share price information for the companies was accurate as of that time.

Keep reading...Show less

Bonus Issue of Options and Other Corporate Updates

US cannabis rescheduling in limbo as new year begins

Cannabis banking reform stalls again in the US

Investor takeaway

US cannabis market

US-focused cannabis fund

1. Green Thumb Industries (CSE:GTII,OTCQX:GTBIF)

2. Trulieve Cannabis (CSE:TRUL,OTCQX:TCNNF)

3. Curaleaf Holdings (TSX:CURA,OTCQX:CURLF)

4. Verano Holdings (NEO:VRNO,OTCQX:VRNOF)

5. Cresco Labs (CSE:CL,OTCQX:CRLBF)

Canadian cannabis market

Canada-based cannabis fund

1. Innovative Industrial Properties (NYSE:IIPR)

2. Jazz Pharmaceuticals (NASDAQ:JAZZ)

3. Cronos Group (NASDAQ:CRON,TSX:CRON)

4. SNDL (NASDAQ:SNDL)

5. Canopy Growth (NASDAQ:CGC,TSX:WEED)

FAQs for investing in cannabis

Are cannabis stocks worth investing in?

Are cannabis stocks considered a high- or low-risk investment?

Why do people buy cannabis stocks?

Latest News

Latest Press Releases

Related News

TOP STOCKS